change, and aligning payment incentives to encourage and support quality improvement. This alignment of payment incentives characterizes P4P and its role in the improvement of health care quality.
Central to P4P program design is the concept of "value-based health care." In the current state of health care, a disproportionate amount of resources and efforts are being spent on patients who are suffering from or who are at high risk for severe disease. This disparity in spending gives short shrift to efforts to promote wellness. In an environment where 46 million Americans do not have access to health insurance, maximizing health derived from limited health care resources is a moral and public health imperative. Value-based health care seeks to create a more uniform continuum of spending across all patient groups, keep healthy people healthy, and help people with early-stage chronic disease from progressing to more serious, complex conditions ( Figure 1 ).
ss Measurement in P4P
Three key principles are fundamental to building a value-based health care system: measurement, transparency, and accountability. These principles are presented in deliberate order. Measurement is the primary concept in improving the quality of health care; without measurement, there is no baseline level of quality against which to gauge improvement. Transparency serves 2 purposes: first, it ensures that quality data is translated into measures and reports that consumers and purchasers can understand and use to make informed decisions. Second, valid measurement is crucial to assigning accountability: those who deliver health care cannot be held accountable for improvement if the quality of care itself is not accurately measured.
Metrics employed in P4P initiatives should be evidence-based and reflect a consensus of key stakeholders. P4P metrics come in 2 forms: measures and guidelines. Measures indicate desired clinical outcomes. For instance, a measure might assess whether a physician' s patients with cardiac conditions control their lowdensity lipoprotein cholesterol (LDL-C) to 100 mg/dL or less. On the other hand, guidelines monitor evidence-based "best-practices" that lead to that desired results; a related guideline would ask whether the same doctor ordered annual cholesterol tests for his cardiac patients. Measures and guidelines alike are useful as measurement tools in P4P programs.
A useful P4P measure is relevant, sound, and feasible: measures that lack these qualities are a waste of time and resources. Relevant measures will be designed to have a significant impact on health outcomes; advance cost-effective, evidence-based methods of care; have strategic significance to practitioners and health plans; and will assess aspects of care that can be improved. Measures must also be sound; that is, specific enough to reliably provide accurate assessments of care. Only trustworthy, evidence-based measures will be embraced by health plans, providers, consumers, and purchasers. Feasible P4P measures are practical for use in the "real world" of health care: they are characterized by precise specifications, a reasonable cost of measurement, and assured confidentiality. Feasible P4P measures also promote accountability by being open to a third-party audit, such as by a health plan or other P4P program sponsor.
The sorts of P4P programs that are possible are driven by 2 factors: the level where measurement takes place-the plan, hospital, or physician office -and the availability of relevant data. Take, for instance, the measurement of pharmacy claims data. Over the short term, limited initiatives at the plan or physician level may arise from pharmacy claims data taken in isolation. However, a more comprehensive pharmacy P4P program would require that those same pharmacy claims be linked to diagnoses or other data that may not be widely collected at the present time.
On the plan level, measurement has led to improved health care, specifically for certain Health Plan Employer Data and Information Set (HEDIS) measures developed by NCQA. In the 5 years from 1999 to 2004, NCQA documented an average increase of more than 52% for HEDIS effectiveness-of-care measures for chicken pox vaccination, hypertension, LDL-C control, LDL-C control among patients with diabetes, and asthma ( Figure 2 ). 2 Similar improvement has also been observed on the physician level, where measurement has also led to advances in clinical quality. For example, performance among applicants to the Diabetes Physician Recognition Program (DPRP) showed substantial improvement in key measures, such as glycosylated hemoglobin (A1C) control, blood pressure control, and lipid control. New NCQA voluntary standards for health plans further influence these efforts through the promotion of standardized measurement and reporting of physician and hospital performance results. The new Physician and Hospital Quality (PHQ) standards have found robust support in the market: the program has earned 37 employer and consumer endorsements and 49 plans are early adopters of PHQ. 6 Plans that voluntarily participate are required to use standardized measures, provide transparency about measurement, share measurement with those being measured, collaborate with other plans contracting with the same providers, and use results for reporting and for other quality improvement (QI) activities.
ss California P4P-IHA One of these programs-IHA' s P4P initiative in California-has demonstrated both longevity and success in the P4P arena. IHA comprises 7 health plans with 6.2 million commercial managed care organization (MCO) enrollees and 225 capitated medical groups that provide for multiple health plans. 7 There are 35,000 physicians in IHA, and Kaiser Permanente joined the association at the end of 2006. 7 In this landmark collaboration, health plans and medical groups agree on measures, and plans combine their data. Clinical data is administrative only in IHA, and patient experience data surveyed at the group level. IT adoption is a performance standard employed by IHA that is evaluated by NCQA; NCQA also serves as the data aggregator. Based on the results of this monitoring, health plans make individual decisions on rewards with P4P recommendations.
The clinical measures employed by IHA have evolved over the past 3 years, from 6 measures in 2003 to 10 measures in 2005: childhood immunizations, cervical cancer screening, breast cancer screening, asthma management, A1C screening, A1C control, LDL-C screening among patients who had a cardiac event, LDL-C control <130 mg/dL for patients who had a cardiac event or were diagnosed with diabetes, chlamydia screening, and appropriate treatment for children with upper respiratory infection. 8 Looking at the third-year results-that is, results reflective of care delivered in 2005-significant improvement was demonstrated in 3 categories: breast cancer screening (64% of physician groups improved in year 3), cervical cancer screening (61% improved), and diabetes: A1C screening and control (54% improved screening).
A particularly notable result arising from the third-year data was an average improvement of 40% among those physician groups who achieved a full IT score. 8 This suggests that adoption of IT facilitates gains in quality. The relationship between IT adoption and clinical quality is most prominently displayed among groups scoring between 0% and 20% of the IT score. Groups who more fully integrated technology into their delivery systems tended to post higher clinical quality scores. NCQA/American Diabetes Association (ADA) Diabetes, including 2,600 physicians; and American Heart Association (AHA)/ American Stroke Association (ASA)/NCQA Heart/Stroke, including 400 physicians. Measures included in these programs include structure, process, and outcomes of excellent care management. More than 3,800 physicians are recognized nationally through these programs, and they are rewarded by many health plans and Bridges to Excellence employers. 6 To earn recognition, physicians must achieve certain standards of care across their entire panel of eligible patients. In the DPRP, for example, the total weight of all the scored measures is 100; physicians must achieve 75% to receive recognition. 9 Between 2003 and 2005, there was a 33% increase in the number of DPRP-recognized physicians. In Bridges to Excellence Diabetes Care Link areas, the increase was particularly striking-the number of recognized physicians increased 450% over the same time frame. 6 ss
Conclusions
The initial data from fledgling P4P programs across the board has indicated that while financial incentives do indeed motivate significant change, nonfinancial support also promotes quality improvement. The engagement of physicians is critical to the P4P movement, and public reporting heightens physician awareness. Experience has shown that actionable feedback on performance is a prerequisite to gains in clinical quality. Data integrity increases trust in the results.
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NCQA' s data on the first wave of P4P programs has indicated that measurement provides physicians with a new perspective on their practice and that practices change their processes and delivery systems in order to meet program standards. National standards appear to be just as difficult to achieve for small and large practices, but having national measures helps reward programs get started. Physicians (i.e., generalists and some specialists) appreciate consistent requirements for measures. Clinical data continues to be difficult to obtain, as chart abstraction, especially in the absence of widespread use of electronic medical records, requires a significant commitment of time and resources.
P4P is not a silver bullet to cure all ills; it is a useful tool to align payment incentives. How a P4P initiative is conducted is just as important as whether it is conducted-it must be based on widely recognized, evidence-based measures and developed in collaboration with the providers it proposes to measure. Measurement and payment functions must be kept separate, and payers are right to be skeptical of additive payments.
The bottom line is that measurement plus rewards equals improvement in health care quality. While initial P4P programs have demonstrated success in improving health care quality, the financial implications of P4P are not yet known since the ROI data pertaining to such programs is incomplete at this time.
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